Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Facile "stop codon" method reveals elevated neuronal toxicity by discrete S87p-α-synuclein oligomers.

Ha Y, Yang A, Lee S, Kim K, Liew H, Suh YH, Park HS, Churchill DG.

Biochem Biophys Res Commun. 2014 Jan 17;443(3):1085-91. doi: 10.1016/j.bbrc.2013.12.099. Epub 2013 Dec 28.

PMID:
24380864
2.

The interplay between lipids and dopamine on α-synuclein oligomerization and membrane binding.

Pham CL, Cappai R.

Biosci Rep. 2013 Oct 22;33(5). pii: e00074. doi: 10.1042/BSR20130092.

3.

Serine 129 phosphorylation of membrane-associated α-synuclein modulates dopamine transporter function in a G protein-coupled receptor kinase-dependent manner.

Hara S, Arawaka S, Sato H, Machiya Y, Cui C, Sasaki A, Koyama S, Kato T.

Mol Biol Cell. 2013 Jun;24(11):1649-60, S1-3. doi: 10.1091/mbc.E12-12-0903. Epub 2013 Apr 10.

4.

Dopamine and Cu+/2+ can induce oligomerization of α-synuclein in the absence of oxygen: Two types of oligomerization mechanisms for α-synuclein and related cell toxicity studies.

Ha Y, Yang A, Lee S, Kim K, Liew H, Lee SH, Lee JE, Lee HI, Suh YH, Park HS, Churchill DG.

J Neurosci Res. 2014 Mar;92(3):359-68. doi: 10.1002/jnr.23323. Epub 2013 Nov 29.

PMID:
24288134
5.

The N-terminal residues 43 to 60 form the interface for dopamine mediated α-synuclein dimerisation.

Leong SL, Hinds MG, Connor AR, Smith DP, Illes-Toth E, Pham CL, Barnham KJ, Cappai R.

PLoS One. 2015 Feb 13;10(2):e0116497. doi: 10.1371/journal.pone.0116497. eCollection 2015.

6.

Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.

Pham CL, Leong SL, Ali FE, Kenche VB, Hill AF, Gras SL, Barnham KJ, Cappai R.

J Mol Biol. 2009 Apr 3;387(3):771-85. doi: 10.1016/j.jmb.2009.02.007. Epub 2009 Feb 11.

PMID:
19361420
7.

Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers.

Lee HJ, Baek SM, Ho DH, Suk JE, Cho ED, Lee SJ.

Exp Mol Med. 2011 Apr 30;43(4):216-22.

8.

Interplay of salicylaldehyde, lysine, and M2+ ions on α-synuclein aggregation: cancellation of aggregation effects and determination of salicylaldehyde neurotoxicity.

Ha Y, Liew H, Park HY, Kim K, Suh YH, Churchill DG.

Neurosci Res. 2011 Oct;71(2):168-77. doi: 10.1016/j.neures.2011.07.003. Epub 2011 Jul 18.

PMID:
21784112
9.

Modulation of human α-synuclein aggregation by a combined effect of calcium and dopamine.

Jain MK, Bhat R.

Neurobiol Dis. 2014 Mar;63:115-28. doi: 10.1016/j.nbd.2013.11.004. Epub 2013 Nov 20.

PMID:
24269918
10.

The structure of dopamine induced alpha-synuclein oligomers.

Rekas A, Knott RB, Sokolova A, Barnham KJ, Perez KA, Masters CL, Drew SC, Cappai R, Curtain CC, Pham CL.

Eur Biophys J. 2010 Sep;39(10):1407-19. doi: 10.1007/s00249-010-0595-x. Epub 2010 Mar 23.

PMID:
20309679
11.

Redox reactions of the α-synuclein-Cu(2+) complex and their effects on neuronal cell viability.

Wang C, Liu L, Zhang L, Peng Y, Zhou F.

Biochemistry. 2010 Sep 21;49(37):8134-42. doi: 10.1021/bi1010909.

12.
13.

Different species of alpha-synuclein oligomers induce calcium influx and seeding.

Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A, Kretzschmar H, Hengerer B, Kostka M.

J Neurosci. 2007 Aug 22;27(34):9220-32.

14.

Cleavage of normal and pathological forms of alpha-synuclein by neurosin in vitro.

Kasai T, Tokuda T, Yamaguchi N, Watanabe Y, Kametani F, Nakagawa M, Mizuno T.

Neurosci Lett. 2008 May 2;436(1):52-6. doi: 10.1016/j.neulet.2008.02.057. Epub 2008 Mar 4.

PMID:
18358605
15.

Redox activity of α-synuclein-Cu is silenced by Zn₇-metallothionein-3.

Meloni G, Vašák M.

Free Radic Biol Med. 2011 Jun 1;50(11):1471-9. doi: 10.1016/j.freeradbiomed.2011.02.003. Epub 2011 Feb 12.

PMID:
21320589
16.

Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation.

Lu JH, Ardah MT, Durairajan SS, Liu LF, Xie LX, Fong WF, Hasan MY, Huang JD, El-Agnaf OM, Li M.

Chembiochem. 2011 Mar 7;12(4):615-24. doi: 10.1002/cbic.201000604. Epub 2011 Jan 26.

PMID:
21271629
17.

Guanidine hydrochloride denaturation of dopamine-induced α-synuclein oligomers: a small-angle X-ray scattering study.

Pham CL, Kirby N, Wood K, Ryan T, Roberts B, Sokolova A, Barnham KJ, Masters CL, Knott RB, Cappai R, Curtain CC, Rekas A.

Proteins. 2014 Jan;82(1):10-21. doi: 10.1002/prot.24332. Epub 2013 Aug 31.

PMID:
23733394
18.

Alpha-Synuclein Fibrils Interact with Dopamine Reducing its Cytotoxicity on PC12 Cells.

Khalife M, Morshedi D, Aliakbari F, Tayaranian Marvian A, Mohammad Beigi H, Azimzadeh Jamalkandi S, Pan-Montojo F.

Protein J. 2015 Aug;34(4):291-303. doi: 10.1007/s10930-015-9625-y.

PMID:
26250981
19.

α-Synuclein oligomers impair neuronal microtubule-kinesin interplay.

Prots I, Veber V, Brey S, Campioni S, Buder K, Riek R, Böhm KJ, Winner B.

J Biol Chem. 2013 Jul 26;288(30):21742-54. doi: 10.1074/jbc.M113.451815. Epub 2013 Jun 6.

20.

Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.

Yamakawa K, Izumi Y, Takeuchi H, Yamamoto N, Kume T, Akaike A, Takahashi R, Shimohama S, Sawada H.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):129-34. doi: 10.1016/j.bbrc.2009.11.015. Epub 2009 Nov 11.

PMID:
19900407

Supplemental Content

Support Center